NHS Insider Trading Activity and SEC Form 4 Filings
NHS insider trading summary
No open-market insider purchases or sales of Neuberger Berman High Yield Strategies Fund Inc. (NHS) have been reported on SEC Form 4 in the past 12 months.
Latest NHS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 17, 2025 | Chris Kocinski | Insider | Buy | $44K (6,000 @ $7.40) |
| May 29, 2025 | Chris Kocinski | Insider | Buy | $112K (15,000 @ $7.44) |
| Jun 7, 2022 | Joseph Lind | Insider | Buy | $46K (5,000 @ $9.14) |
| Jun 6, 2022 | Joseph Lind | Insider | Buy | $46K (5,000 @ $9.25) |
| Jun 3, 2022 | MetLife Investment Management, LLC | 10% Owner | Buy | $702250.00B (26,500,000 @ $26500000.00) |
| Dec 11, 2020 | Boaz Weinstein | 10% Owner | Sell | $1.2M (100,000 @ $11.85) |
| Dec 11, 2020 | Saba Capital Management, L.P. | 10% Owner | Sell | $1.2M (100,000 @ $11.85) |
| Aug 4, 2020 | MetLife Investment Management, LLC | Insider | Buy | $21.0M (1,680,000 @ $12.50) |
| Aug 4, 2020 | MetLife Investment Management, LLC | Insider | Buy | $62.0M (4,960,000 @ $12.50) |
| Aug 4, 2020 | MetLife Investment Management, LLC | Insider | Buy | $12.0M (960,000 @ $12.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.